LYVISPAH
NDC 87519-003, baclofen, granule, from Anvi Pharmaceuticals Inc.
- Product NDC
- 87519-003
- Status
- Listed
- Labeler
- Anvi Pharmaceuticals Inc
- Dosage form
- GRANULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215422
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/87519-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BACLOFEN10 mg/1
Pharmacologic classes
GABA A Agonists [MoA]; GABA B Agonists [MoA]; gamma-Aminobutyric Acid-ergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 87519-003-90 | 87519000390 | 90 PACKET in 1 CARTON (87519-003-90) / 1 GRANULE in 1 PACKET |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5b13c40d-a109-f838-e063-6294a90aecf2
Use it
Look up 87519-003 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/87519-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 87519-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.